Form 8.3 - Horizon Therapeutics plc

Barclays PLC
02 May 2023
 

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,

TAKEOVER RULES, 2007 (AS AMENDED)

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES

REPRESENTING 1% OR MORE

1.

KEY INFORMATION

Name of person dealing (Note 1)

Barclays PLC.

Company dealt in

HORIZON THERAPEUTICS PLC

Class of relevant security to which the dealings being disclosed relate (Note 2)

$0.001 ordinary shares

Date of dealing

01 May 2023

 

2.

INTERESTS AND SHORT POSITIONS

(a)

Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Class of relevant security:

$0.001 ordinary shares


Long

Short

Number

(%)

Number

(%)

(1)

Relevant securities 

1,424,704

0.62%

373,438

0.16%

(2)

Derivatives (other than options):

53,770

0.02%

0

0.00%

(3)

Options and agreements to purchase/sell:

1,217,700

0.53%

997,200

0.44%

TOTAL:

2,696,174

1.18%

1,370,638

0.60%

 

(b)

Interests and short positions in relevant securities of the company, other than the class dealt in

Class of relevant security:

Long

Short

Number

(%)

Number

(%)

(1)

Relevant securities

 

 

 

 

(2)

Derivatives (other than options):

 

 

 

 

(3)

Options and agreements to purchase/sell:

 

 

 

 

TOTAL:

 

 

 

 

 

3.

DEALINGS (Note 4)

(a)

Purchase and sales

 






Class of relevant Security

Purchase/sale

Number of securities

Price per unit

$0.001 ordinary shares

Purchase

2

                 111.8400 USD

$0.001 ordinary shares

Purchase

31

                 111.9090 USD

$0.001 ordinary shares

Purchase

54

                 111.8707 USD

$0.001 ordinary shares

Purchase

100

                 111.9100 USD

$0.001 ordinary shares

Purchase

179

                 111.9500 USD

$0.001 ordinary shares

Purchase

200

                 111.8000 USD

$0.001 ordinary shares

Purchase

200

                 111.9050 USD

$0.001 ordinary shares

Purchase

326

                 111.5795 USD

$0.001 ordinary shares

Purchase

400

                 111.7575 USD

$0.001 ordinary shares

Purchase

600

                 111.9000 USD

$0.001 ordinary shares

Purchase

653

                 111.6822 USD

$0.001 ordinary shares

Purchase

800

                 111.8706 USD

$0.001 ordinary shares

Purchase

1,559

                 111.7615 USD

$0.001 ordinary shares

Purchase

1,695

                 111.8689 USD

$0.001 ordinary shares

Purchase

1,931

                 111.7330 USD

$0.001 ordinary shares

Purchase

2,329

                 111.8891 USD

$0.001 ordinary shares

Purchase

3,343

                 111.9295 USD

$0.001 ordinary shares

Purchase

5,582

                 111.7890 USD

$0.001 ordinary shares

Purchase

10,000

                 111.8107 USD

$0.001 ordinary shares

Purchase

12,516

                 111.8485 USD

$0.001 ordinary shares

Sale

1

                 111.8400 USD

$0.001 ordinary shares

Sale

4

                 111.8500 USD

$0.001 ordinary shares

Sale

6

                 111.8733 USD

$0.001 ordinary shares

Sale

12

                 111.5200 USD

$0.001 ordinary shares

Sale

29

                 111.8769 USD

$0.001 ordinary shares

Sale

43

                 111.9000 USD

$0.001 ordinary shares

Sale

100

                 111.8000 USD

$0.001 ordinary shares

Sale

198

                 111.9139 USD

$0.001 ordinary shares

Sale

200

                 111.8100 USD

$0.001 ordinary shares

Sale

202

                 111.8374 USD

$0.001 ordinary shares

Sale

553

                 111.8057 USD

$0.001 ordinary shares

Sale

585

                 111.1591 USD

$0.001 ordinary shares

Sale

594

                 111.8290 USD

$0.001 ordinary shares

Sale

807

                 111.8257 USD

$0.001 ordinary shares

Sale

1,025

                 111.6895 USD

$0.001 ordinary shares

Sale

1,152

                 111.8281 USD

$0.001 ordinary shares

Sale

1,288

                 111.9500 USD

$0.001 ordinary shares

Sale

1,732

                 111.7123 USD

$0.001 ordinary shares

Sale

1,896

                 111.7304 USD

$0.001 ordinary shares

Sale

2,325

                 111.8892 USD

$0.001 ordinary shares

Sale

2,674

                 111.9172 USD

$0.001 ordinary shares

Sale

4,722

                 111.8556 USD

$0.001 ordinary shares

Sale

5,529

                 111.7887 USD

$0.001 ordinary shares

Sale

6,391

                 111.8036 USD

$0.001 ordinary shares

Sale

11,017

                 111.8532 USD

 

(b)

Derivatives transactions (other than option transactions)

Product Name

Nature of transaction

Number of relevant securities

Price per unit

 

 

 

 

 
















(c)

Options transactions in respect of existing securities

(i)

Writing, selling, purchasing or varying

Class

 of

 relevant

 security

Product

 description

Writing,

 purchasing,

 selling,

 varying etc

Number

 of

 securities

 to which

 option

 relates

Exercise

 price

 per unit

Type

Expiry

 date

Option

 money

 paid/

 received

 per unit

 

 

 

 

 

 

 

 

 
















(ii)

Exercising

 






Product name

Number of

 securities

Exercise price

 per unit

 

 

 

 
















(d)

Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

Details

Price per unit

 (if applicable)

 

 

 

4.

OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing

 and any other person relating to the voting rights of any relevant securities under any option

 referred to on this form or relating to the voting rights or future acquisition or disposal of any

 relevant securities to which any derivative referred to on this form is referenced. If none, this

 should be stated.

NONE

Is a Supplemental Form 8 (Open Positions) attached?

YES

Date of disclosure:

02 May 2023

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

If a connected EFM, name of offeree/offeror with which connected

 

If a connected EFM, state nature of connection

 

 

SUPPLEMENTAL FORM 8

 








IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL

ACT, 1997, TAKEOVER RULES, 2007 (AS AMENDED)

DETAILS OF OPEN POSITIONS

(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as

appropriate)

OPEN POSITIONS

 







Class of relevant

 security

Product

 Description

Writing,

 purchasing,

 selling,

 varying etc

Number

 of

 securities

 to which

 option

 relates

Exercise

 price

 per unit

Type

Expiry

 date

$0.001 ordinary shares

Put Options

Written

150,000

090

American

19 May 2023

$0.001 ordinary shares

Put Options

Written

495,500

100

American

16 Jun 2023

$0.001 ordinary shares

Put Options

Purchased

-25,000

085

American

19 May 2023

$0.001 ordinary shares

Put Options

Written

10,200

080

American

18 Aug 2023

$0.001 ordinary shares

Put Options

Written

400,000

100

American

18 Aug 2023

$0.001 ordinary shares

Put Options

Purchased

-800,000

080

American

18 Aug 2023

$0.001 ordinary shares

Put Options

Written

162,000

105

American

21 Jul 2023

$0.001 ordinary shares

Put Options

Purchased

-162,000

090

American

21 Jul 2023

$0.001 ordinary shares

Put Options

Purchased

-10,200

100

American

18 Aug 2023

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 

Companies

Barclays (BARC)
UK 100

Latest directors dealings